Mutual Advisors LLC Has $746,000 Stake in Colgate-Palmolive (NYSE:CL)

Mutual Advisors LLC trimmed its stake in Colgate-Palmolive (NYSE:CLFree Report) by 45.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,420 shares of the company’s stock after selling 6,947 shares during the period. Mutual Advisors LLC’s holdings in Colgate-Palmolive were worth $746,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Wesbanco Bank Inc. boosted its position in shares of Colgate-Palmolive by 1.7% during the 4th quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock valued at $1,370,000 after acquiring an additional 250 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Colgate-Palmolive by 2.2% during the 4th quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock valued at $35,227,000 after acquiring an additional 8,293 shares in the last quarter. Atomi Financial Group Inc. boosted its position in shares of Colgate-Palmolive by 6.5% during the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock valued at $590,000 after acquiring an additional 394 shares in the last quarter. Crossmark Global Holdings Inc. boosted its position in shares of Colgate-Palmolive by 4.3% during the 4th quarter. Crossmark Global Holdings Inc. now owns 173,831 shares of the company’s stock valued at $15,803,000 after acquiring an additional 7,105 shares in the last quarter. Finally, Ballentine Partners LLC boosted its position in shares of Colgate-Palmolive by 2.2% during the 4th quarter. Ballentine Partners LLC now owns 21,007 shares of the company’s stock valued at $1,910,000 after acquiring an additional 460 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CL shares. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. UBS Group reduced their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $101.11.

View Our Latest Report on CL

Colgate-Palmolive Trading Down 0.0 %

CL opened at $87.88 on Monday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $71.79 billion, a price-to-earnings ratio of 25.18, a price-to-earnings-growth ratio of 3.59 and a beta of 0.44. The firm has a 50 day simple moving average of $91.81 and a 200 day simple moving average of $97.45. Colgate-Palmolive has a fifty-two week low of $80.03 and a fifty-two week high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.34% of the stock is currently owned by insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.